Chevallard Daniel R. 4
4 · LENZ Therapeutics, Inc. · Filed May 15, 2024
Insider Transaction Report
Form 4
Chevallard Daniel R.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2024-05-14$15.68/sh+3,188$49,988→ 3,188 total
4 · LENZ Therapeutics, Inc. · Filed May 15, 2024
Common Stock